Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Unger

Showing results (21-30 of 239) with videos related to

Pageof 24
Sort By:
Blood Pressure|June 12, 2003
Angiotensin AT1/AT2 receptors: regulation, signalling and functionElena Kaschina, Thomas Unger
Expert Opinion on Pharmacotherapy|May 25, 2004
Challenges in improving prognosis and therapy: the Ongoing Telmisartan Alone and in Combination with Ramipril Global End point Trial programmeMathias Zimmermann, Thomas Unger
Future Cardiology|October 7, 2009
Telmisartan: from lowering blood pressure to end-organ protectionThomas Unger, Michael Schupp
Drug Safety|July 17, 2003
Drug interactions with angiotensin receptor blockers: a comparison with other antihypertensivesThomas Unger, Elena Kaschina
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|June 10, 2003
Angiotensin II receptor expression: from maturation to pathogenesisUlrich Kintscher, Thomas Unger
Cardiology|May 3, 2013
Plasma renin and cardiovascular risk: what is the evidence for an association?Massimo Volpe, Thomas Unger
Drugs|May 31, 2002
[Pathophysiological and clinical implications of AT(1)/AT(2) angiotensin II receptors in heart failure and coronary and renal failure]Steffen Sandmann, Thomas Unger
Nature Reviews. Cardiology|June 23, 2010
Novel therapeutic targets for hypertensionLudovit Paulis, Thomas Unger
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 5, 2004
The role of the renin-angiotensin-aldosterone system in heart failureThomas Unger, Jun Li
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 14, 2006
Mast cells and the power of local RAS activationHarm Peters, Thomas Unger
Pageof 24

Showing results (21-30 of 239) with videos related to

Sort By:
Pageof 24
Blood Pressure|June 12, 2003
Angiotensin AT1/AT2 receptors: regulation, signalling and functionElena Kaschina, Thomas Unger
Expert Opinion on Pharmacotherapy|May 25, 2004
Challenges in improving prognosis and therapy: the Ongoing Telmisartan Alone and in Combination with Ramipril Global End point Trial programmeMathias Zimmermann, Thomas Unger
Future Cardiology|October 7, 2009
Telmisartan: from lowering blood pressure to end-organ protectionThomas Unger, Michael Schupp
Drug Safety|July 17, 2003
Drug interactions with angiotensin receptor blockers: a comparison with other antihypertensivesThomas Unger, Elena Kaschina
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|June 10, 2003
Angiotensin II receptor expression: from maturation to pathogenesisUlrich Kintscher, Thomas Unger
Cardiology|May 3, 2013
Plasma renin and cardiovascular risk: what is the evidence for an association?Massimo Volpe, Thomas Unger
Drugs|May 31, 2002
[Pathophysiological and clinical implications of AT(1)/AT(2) angiotensin II receptors in heart failure and coronary and renal failure]Steffen Sandmann, Thomas Unger
Nature Reviews. Cardiology|June 23, 2010
Novel therapeutic targets for hypertensionLudovit Paulis, Thomas Unger
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 5, 2004
The role of the renin-angiotensin-aldosterone system in heart failureThomas Unger, Jun Li
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 14, 2006
Mast cells and the power of local RAS activationHarm Peters, Thomas Unger
Pageof 24